Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
BETA Stock Analysis
Views
Red Flags
Positive
Consistently pays dividend
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
BETA Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
BETA Bulk, Block & Insider Trades
BETA Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
Bonus
Bonus(1 new shares for 20 existing shares) Ex-date: 26th Mar 2025 Announced on: 5th Feb 2025
Company Profile
Beta Drugs Limited is an India-based oncology medicine manufacturing company. The Company specializes in the intricate field of complex chemical synthesis for anti-cancer bulk drugs and finished dosages. The Company operates through one segment, Pharmaceuticals. Its product category includes cosmece... Read More
Key personnel
Mr. Vijay Kumar BatraD
Chairman of the Board, Managing Director
Mr. Jayant Kumar
Chief Financial Officer
Ms. Rajni Brar
Compliance Officer, Company Secretary
Ms. Neeraj BatraD
Whole Time Director
Mr. Rahul BatraD
Whole Time Director
Mr. Varun BatraD
Whole Time Director
Mr. Balwant SinghD
Whole Time Director
Mr. Nipun AroraD
Additional Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Beta Drugs Ltd.?
The current share price of Beta Drugs Ltd. is ₹ 1,585.00 as of 09 Jan 2026.
What is the PE ratio of Beta Drugs Ltd.?
The Price-to-Earnings (PE) ratio of Beta Drugs Ltd. is 37.72 as of the latest financial data.
What is the ROE and ROCE of Beta Drugs Ltd.?
Beta Drugs Ltd. has a Return on Equity (ROE) of 23.95% and a Return on Capital Employed (ROCE) of 24.76% as per the latest financial reports.
What is the market cap of Beta Drugs Ltd.?
The market capitalization of Beta Drugs Ltd. stands at ₹ 1,600.06 Cr.
What is the dividend yield of Beta Drugs Ltd.?
The dividend yield of Beta Drugs Ltd. is 0.00% based on the current market price.
What is the RSI of Beta Drugs Ltd.?
The Relative Strength Index (RSI) of Beta Drugs Ltd. is 45.87.
What is the FII and DII holding in Beta Drugs Ltd.?
Foreign Institutional Investors (FII) hold 0.90% and Domestic Institutional Investors (DII) hold 0.00% of Beta Drugs Ltd. shares.
What sector does Beta Drugs Ltd. belong to?
Beta Drugs Ltd. operates in the Healthcare sector.
What is the beta of Beta Drugs Ltd. stock?
The beta of Beta Drugs Ltd. stock is 1.08, indicating its volatility relative to the broader market.
